G

GE Healthcare

Imaging, monitoring, and healthcare IT solutions

Senior AI/ML Engineer

Full-TimeUpdated on 10/14/2026
No salary listed
Senior, Expert
Bachelor's, Master's
Seongnam-si, Gyeonggi-do, South Korea
In Person
AI & Machine LearningApplied Machine Learning

About the job

Requirements
  • A bachelor's degree in data science, computer science, statistics, engineering, or a related field is required.
  • Eight to twelve years of experience in data science, machine learning, or advanced analytics is required.
  • Strong experience in machine learning model development, evaluation, and deployment is required.
  • Proficiency in Python, R, or similar programming languages, and data handling frameworks such as Pandas and NumPy is required.
  • Hands-on experience with machine learning frameworks such as TensorFlow, PyTorch, and Scikit-learn is required.
  • Experience in data pipeline development and large-scale data processing technologies is required.
  • Understanding of the software development lifecycle and model validation and testing practices is required.
  • Experience in object-oriented design methodology and programming languages including C/C++ and C# is required.
  • Working knowledge of cloud environments such as Azure, AWS, or GCP and data platforms is required.
  • Business-level English communication skills for global collaboration are required.
Responsibilities
  • Develop and implement machine learning models, statistical analyses, and AI algorithms to enhance product functionality and performance.
  • Own end-to-end model development, including data preparation, model training, evaluation, and validation.
  • Implement scalable and efficient data pipelines to support model development and deployment.
  • Collaborate with software engineers and system teams to integrate machine learning models into production systems.
  • Support model deployment, monitoring, and performance optimization in production environments.
  • Participate in technical discussions and provide guidance to junior engineers.
  • Collaborate with global teams to ensure consistency, reusability, and scalability of data science solutions.
  • Implement validation and testing approaches to ensure model accuracy, robustness, and reliability.
  • Comply with the GE Healthcare Quality Manual, Quality Management System, Quality Management Policy, Quality Goals, and applicable laws and regulations.
  • Complete planned Quality and Compliance training within defined deadlines.
  • Identify and report quality or compliance concerns and take immediate corrective action as required.
  • Support compliance and closure of Regulatory and Quality requirements before completing Design Outputs and Program Deliverables.
  • Participate in continuous improvement activities by identifying and escalating process and product quality gaps, and providing solutions when possible.
Desired Qualifications
  • A master's degree in data science, computer science, AI, statistics, or a related field is preferred.
  • Experience in healthcare data, medical imaging, or regulated environments is preferred.
  • Demonstrated C++/Python experience, especially in image processing or medical image processing, is preferred.
  • Familiarity with CUDA/OpenCL/GPGPU programming is preferred.
  • Hands-on experience implementing real-time software is preferred.
  • Knowledge of optimization techniques for running AI models on GPU is preferred.
  • Strong working knowledge of SQL for data querying is preferred.
  • Strong knowledge of MLOps, model governance, and explainable AI (XAI) is preferred.
  • Similar experience with ultrasound equipment or medical devices is preferred.

About the company

GE Healthcare Systems provides medical technologies and digital infrastructure to improve diagnosis, treatment, and monitoring of patients. Its products include imaging systems, mobile diagnostic devices, patient monitoring tools, and healthcare IT software that work together as hardware, software, and services to support hospitals, clinics, and researchers. The company differentiates itself with a large, integrated ecosystem, strong focus on AI analytics, and a global service network backed by substantial R&D investment. Its goal is to improve patient outcomes and the efficiency of healthcare delivery by enabling accurate diagnoses, effective treatments, and scaled operations.

Company Size

1-10

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

1892

Get referred to GE Healthcare

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 orders rose 11% and backlog reached a record $23.9 billion.
  • CareIntellect for Operations launched September 2026 with Duke Health and Queen's Health Systems.
  • CE mark and FDA progress for Photonova Spectra expand 2026-2027 commercial momentum.

What critics are saying

  • FDA logged multiple 2026 Class 2 recalls, including AW Server and telemetry systems.
  • Patient Care Solutions remained weak in Q2 2026; management is reviewing a sale.
  • SOFIE closes only after 2027 regulatory approvals; PET supply integration can slip badly.

What makes GE Healthcare unique

  • GE HealthCare combines imaging hardware, radiopharmaceuticals, and workflow software across hospitals.
  • Photonova Spectra and Vivid 2026 show premium innovation plus AI-enabled clinical automation.
  • SOFIE's 21 cyclotrons extend GE HealthCare into radiotracer manufacturing, not just scanners.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Relocation Assistance

Company News

Business Wire
Oct 5th, 2026
GE HealthCare to acquire SOFIE Biosciences for $945M to expand US radiopharmaceutical supply

GE HealthCare has agreed to acquire SOFIE Biosciences, a US-based contract manufacturer of PET radiopharmaceuticals, for $945 million in cash. The deal with seller Trilantic North America is expected to close in the first half of 2027, subject to regulatory approvals. SOFIE Biosciences operates 15 contract manufacturing sites with 21 cyclotrons across the US, plus a theranostics-focused development and manufacturing facility. The acquisition establishes GE HealthCare's presence in the time-critical "final mile" of US PET radiopharmaceutical supply. The PET radiopharmaceutical market is expanding rapidly with approximately 20 PET radiotracers and over 30 radiotherapeutics currently under development. SOFIE Biosciences' portfolio includes a Phase III FAPI asset for which GE HealthCare already holds non-US rights. GE HealthCare estimates the transaction will be accretive to revenue growth, earnings margin, and earnings per share in the first full year of ownership.

PR Newswire
Sep 30th, 2026
AsiaMedic first in ASEAN to deploy GE HealthCare's MR31 deep learning MRI platform

AsiaMedic has become the first site in ASEAN to implement MR31, GE HealthCare's latest generation MRI platform featuring deep learning technology. The Singapore-based imaging centre is among the earliest adopters in Asia Pacific. MR31 incorporates deep learning technologies that reduce scan times and enable detailed examinations across neurological, musculoskeletal and nerve imaging. Sonic DL for 3D delivers up to 12 times scan acceleration, reducing examination times across brain, spine, orthopaedic and body scans. The platform also supports high-quality prostate MRI imaging. AIR Recon DL Phase Correction provides improved visualisation of clinically significant lesions, whilst high-resolution T2-weighted imaging aids lesion localisation for prostate fusion biopsy planning. Shorter scan times mean reduced patient time in scanners and may help decrease repeat examinations caused by movement.

Associated Press
Sep 22nd, 2026
GE HealthCare raises quarterly dividend 14% to $0.04 per share for Q3 2026

GE HealthCare Technologies announced a 14% dividend increase for the third quarter of 2026. The company's board declared a cash dividend of $0.04 per share, up from the previous quarter. The dividend will be paid on 13 November 2026 to shareholders of record as of 23 October 2026. GE HealthCare is a global healthcare solutions provider specialising in medical technology, pharmaceutical diagnostics, and AI-enabled software solutions. The company operates a $20.6 billion business with approximately 54,000 employees worldwide, serving the healthcare industry through its Advanced Imaging Solutions, Pharmaceutical Diagnostics, and Patient Care Solutions segments.

Yahoo Finance
Sep 15th, 2026
GE HealthCare launches AI tool to forecast hospital capacity bottlenecks 72 hours ahead

GE HealthCare has launched CareIntellect for Operations, an AI-powered software application that helps health systems forecast capacity constraints up to 72 hours ahead. The solution analyses hundreds of patient and operational data points to predict bottlenecks and recommend actions to optimise capacity and throughput. The Queen's Health Systems and Duke Health will be the first to implement the application. It uses two proprietary AI models: the Pressure Forecast model, which predicts resource constraints across hospitals and departments, and the Estimated Day of Discharge model, which predicts when patients will be discharged. The tool addresses operational challenges as US inpatient volumes rose 5.3% in 2025, requiring health systems to manage increased demand whilst facing staffing shortages and rising costs.

Yahoo Finance
Sep 1st, 2026
GE HealthCare secures CE mark for Photonova Spectra photon-counting CT system

GE HealthCare has received CE mark approval for its Photonova Spectra photon-counting computed tomography system, enabling commercial sales in markets recognising CE marking. The clearance follows US Food and Drug Administration approval and Japanese regulatory clearance in March 2026. The system uses GE HealthCare's Deep Silicon detector technology to deliver ultra-high definition spectral and spatial imaging. It processes data volumes up to 50 times greater than conventional CT systems, utilising Nvidia's accelerated computing platform. Clinical collaborations are underway at UZ Brussel in Belgium and Rigshospitalet in Denmark to evaluate the system across cardiology, neurology, oncology and musculoskeletal imaging. The CE mark follows more than $5 billion in innovation investment by GE HealthCare.